Suppression of chronic damage in renal allografts by liver X receptor (LXR) activation: Relevant contribution of macrophage LXRα

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 92-103

  Kiss, Eva ^a   Popovic, Zoran ^a   Bedke, Jens ^a   Wang, Shijun ^a   Bonrouhi, Mahnaz ^a   Gretz, Norbert ^b   Stettner, Paula ^a   Teupser, Daniel ^c   Thiery, Joachim ^c   Porubsky, Stefan ^a   Adams, Judith ^a   Gröne, Hermann Josef ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ARGINASE 1; INTERLEUKIN 13; INTERLEUKIN 4; LIVER X RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANNOSE RECEPTOR; MANNOSE RECEPTOR C TYPE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW; CELL INFILTRATION; CELL SPECIFICITY; CELL STRUCTURE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DISEASE SEVERITY; GENE OVEREXPRESSION; KIDNEY ALLOGRAFT; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; BENZOIC ACIDS; BENZYLAMINES; BLOTTING, WESTERN; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; FIBROSIS; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOENZYME TECHNIQUES; KIDNEY TRANSPLANTATION; LIGANDS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; ORPHAN NUCLEAR RECEPTORS; RATS; RATS, INBRED F344; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052494631     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.019     Document Type: Article

References (39)

1. Yates PJ, Nicholson ML: The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006, 16:148-157
2. Joosten SA, Sijpkens YW, van Kooten C, Paul LC: Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005, 68:1-13
3. Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ: The role of macrophages in allograft rejection. Transplantation 2005, 80:1641-1647
4. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483
5. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris DC: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007, 72:290-299
6. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA: Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009, 5:e1000371
7. Dehmel S, Wang S, Schmidt C, Kiss E, Loewe RP, Chilla S, Schlöndorff D, Gröne HJ, Luckow B: Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. Eur J Immunol 2010, 40:267-278
8. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B: Role of LXRs in control of lipogenesis. Genes Dev 2000, 14:2831-2838
9. Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, Plunket KD, Morgan DG, Beaudet EJ, Whitney KD, Kliewer SA, Willson TM: Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002, 45:1963-1966
10. Repa JJ, Mangelsdorf DJ: The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 2002, 8:1243-1248
11. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD, Tontonoz P: LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008, 134:97-111
12. Hong C, Tontonoz P: Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 2008, 18: 461-467
13. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK: Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721
14. Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P: Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 2003, 278:10443-10449
15. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P: Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003, 9:213-219
16. Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, Tontonoz P, Castrillo A: The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 2006, 281: 32197-32206
17. Teupser D, Kretzschmar D, Tennert C, Burkhardt R, Wilfert W, Fengler D, Naumann R, Sippel AE, Thiery J: Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:2009-2015
18. Adams J, Kiss E, Arroyo AB, Bonrouhi M, Sun Q, Li Z, Gretz N, Schnitger A, Zouboulis CC, Wiesel M, Wagner J, Nelson PJ, Gröne HJ: 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol 2005, 167:285-298
19. Bedke J, Kiss E, Schaefer L, Behnes CL, Bonrouhi M, Gretz N, Horuk R, Diedrichs-Moehring M, Wildner G, Nelson PJ, Gröne HJ: Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant 2007, 7:527-537
20. Li N, Rivéra-Bermúdez MA, Zhang M, Tejada J, Glasson SS, Collins-Racie LA, Lavallie ER, Wang Y, Chang KC, Nagpal S, Morris EA, Flannery CR, Yang Z: LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model. Proc Natl Acad Sci U S A 2010, 107:3734-3739
21. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Gröne HJ: Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIF-dependent signaling. Dis Model Mech 2010, 3:92-103
22. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J: Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a highperformance liquid chromatography assay. Kidney Int 2007, 71: 74-78
23. Kiss E, Adams J, Grone HJ, Wagner J: Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 2003, 76:480-489
24. Weischenfeldt J, Porse B: Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc 2008; doi:10.1101/pdb.prot5080
25. Gersuk GM, Razai LW, Marr KA: Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1. J Immunol Methods 2008, 329:157-166
26. Porubsky S, Wang S, Kiss E, Dehmel S, Bonrouhi M, Dorn T, Luckow B, Brakebusch C, Gröne HJ: Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection. Eur J Immunol 2011, 41:76-88
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
28. Chisholm JW, Hong J, Mills SA, Lawn RM, Jeffrey W: The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 2003, 44:2039-2048
29. Geyeregger R, Shehata M, Zeyda M, Kiefer FW, Stuhlmeier KM, Porpaczy E, Zlabinger GJ, Jäger U, Stulnig TM: Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 2009, 86:1039-1048
30. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR: The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009, 30:575-579
31. von Toerne C, Schmidt C, Adams J, Kiss E, Bedke J, Porubsky S, Gretz N, Lindenmeyer MT, Cohen CD, Gröne HJ, Nelson PJ: Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 2009, 9:2223-2239
32. White E, Hildemann WH, Mullen Y: Chronic kidney allograft reactions in rats. Transplantation 1969, 8:602-617
33. Blaschke F, Leppanen O, Takata Y, Caglayan E, Liu J, Fishbein MC, Kappert K, Nakayama KI, Collins AR, Fleck E, Hsueh WA, Law RE, Bruemmer D: Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in ballooninjured rat carotid arteries. Circ Res 2004, 95:e110-e123
34. Hultén LM, Lindmark H, Diczfalusy U, Björkhem I, Ottosson M, Liu Y, Bondjers G, Wiklund O: Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 1996, 97:461-468
35. Rowe AH, Argmann CA, Edwards JY, Sawyez CG, Morand OH, Hegele RA, Huff MY: Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene: lanosterol cyclase. Circ Res 2003, 93:717-725
36. Shibata N, Glass CK: Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res 2009, 50(Suppl):S277-S281
37. Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. J Clin Invest 2008, 118:3522-3530
38. Varin A, Gordon S: Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214:630-641
39. Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G: Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142:481-489